Cognitive dysfunction and dementia are common in Parkinson disease
The new drug, dalzanemdor, unfortunately seems to not be working as a potential treatment for Parkinson's / mild cognitive impairment.
References:
Saltzman, Jonathanb
Sage Therapeutics stock plunges 20 percent after Parkinson’s drug fails study
Boston Globe
www.bostonglobe.com/2024/04/1...
Robert L Rodnitzky, MD
Cognitive impairment and dementia in Parkinson disease
Uptodate
www.uptodate.com/contents/cog...
Sage Therapeutics Website:
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
investor.sagerx.com/news-rele...
Негізгі бет Parkinson's disease treatment
Пікірлер: 1